Transcellular distribution heterogeneity of Annexin A5 represents a protective response to lupus-related thrombophilia: A pilot Proteomics-based study

Biochemical and Biophysical Research Communications

Volumn 420, Issue 2, 2012, Pages 357-363

  Zhou, Di ^a   Luo, Na ^a   Wu, Qiao ^a   You, Yi ^a   Zhai, Zhifang ^a   Mou, Zhirong ^a   Wu, Yuzhang ^a   Hao, Fei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Annexin A5; Proteomics; Systemic lupus erythematosus; Thrombophilia

Indexed keywords

ALPHA ENOLASE; DYNAMIN I; ELONGATION FACTOR 1ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN; INTEGRIN LINKED KINASE; LIPOCORTIN 5; PHOSPHOGLYCERATE KINASE; PROTEIN TYROSINE KINASE; TRANSKETOLASE; TRIOSEPHOSPHATE ISOMERASE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LUPUS RELATED THROMBOPHILIA; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; PROTHROMBIN TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBIN TIME; THROMBOPHILIA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANNEXIN A5; CHILD; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PILOT PROJECTS; PROTEOMICS; THROMBOPHILIA; YOUNG ADULT;

EID: 84862789905     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.162     Document Type: Article

References (28)

1. Merrell M., Shulman L.E. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J. Chronic Dis. 1955, 1:12-32.
2. Decker J.L., Klippel J.H., Plotz P.H., et al. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28months. Ann. Intern. Med. 1975, 83:606-615.
3. Kasitanon N., Magder L.S., Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006, 85:147-156.
4. Rosner S., Ginzler E.M., Diamond H.S., et al. Arthritis. Rheum. 1982, 25:612-617.
5. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 2003, 82:299-308.
6. Deng Y., Tsao B.P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 2010, 6:683-692.
7. Shao W.H., Cohen P.L. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis. Res. Ther. 2011, 13:202.
8. Nakou M., Bertsias G., Stagakis I., et al. Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS One 2010, 5:e13351.
9. Van Heerde W.L., Reutelingsperger C.P., Maassen C., et al. The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma. J. Thromb. Haemost. 2003, 1:532-536.
10. Zheng H., Chen Y., Ao W., et al. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res. Ther. 2009, 11:R93.
11. Dai Y., Hu C., Huang Y., et al. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 2008, 17:799-804.
12. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
13. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 2002, 29:288-291.
14. He Y.J., Wu Y.Z., Mou Z.R., et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. Proteomics Clin. Appl. 2007, 1:336-342.
15. Xia R.S., Hao F., Mou Z.R., et al. Identification of proteins involved in aggregation of human dermal papilla cells by proteomics. J. Dermatol. Sci. 2007, 48:189-197.
16. Gharahdaghi F., Weinberg C.R., Meagher D.A., et al. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20:601-605.
17. Gerke V., Moss S.E. Annexins: from structure to function. Physiol. Rev. 2002, 82:331-371.
18. Rand J.H., Wu X.X., Andree H.A., et al. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N. Engl. J. Med. 1997, 337:154-160.
19. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome APS. J. Thromb. Haemost. 2006, 4:295-306.
20. Kenis H., van Genderen H., Bennaghmouch A., et al. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 2004, 279:52623-52629.
21. Ravassa S., Bennaghmouch A., Kenis H., et al. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoir. J. Biol. Chem. 2005, 280:6028-6035.
22. Tinazzi E., Dolcino M., Puccetti A., et al. Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res. Ther. 2010, 12:R131.
23. Matsuda J., Saitoh N., Gohchi K., et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am. J. Hematol. 1994, 47:56-58.
24. Lakos G., Kiss E., Regeczy N., et al. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J. Rheumatol. 2000, 27:924-929.
25. Hrycek A., Cieslik P. Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus. Rheumatol. Int. 2011.
26. Wang W., Xu J., Kirsch T. Annexin-mediated Ca2+ influx regulates growth plate chondrocyte maturation and apoptosis. J. Biol. Chem. 2003, 278:3762-3769.
27. Uchiumi T., Traut R.R., Elkon K., et al. A human autoantibody specific for a unique conserved region of 28 S ribosomal RNA inhibits the interaction of elongation factors 1 alpha and 2 with ribosomes. J. Biol. Chem. 1991, 266:2054-2062.
28. Furnrohr B.G., Wach S., Kelly J.A., et al. Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Ann. Rheum. Dis. 2010, 69:1983-1989.